These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24443270)
21. Major effects on blood-retina barrier passage by minor alterations in design of polybutylcyanoacrylate nanoparticles. You Q; Hopf T; Hintz W; Rannabauer S; Voigt N; van Wachem B; Henrich-Noack P; Sabel BA J Drug Target; 2019 Mar; 27(3):338-346. PubMed ID: 30280953 [TBL] [Abstract][Full Text] [Related]
22. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles. Jin X; Huang A; Ping Q; Cao F; Su Z Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067 [TBL] [Abstract][Full Text] [Related]
23. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles. Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943 [TBL] [Abstract][Full Text] [Related]
24. Design, Preparation, and Evaluation of Osthol Poly-Butyl-Cyanoacrylate Nanoparticles with Improved In Vitro Anticancer Activity in Neuroblastoma Treatment. Zheng L; Shen L; Li Z; Zhang X; Wu M; Zhang Y; Liu J Molecules; 2022 Oct; 27(20):. PubMed ID: 36296500 [TBL] [Abstract][Full Text] [Related]
25. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres. Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657 [TBL] [Abstract][Full Text] [Related]
26. Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells. Kuo YC; Chung CY Colloids Surf B Biointerfaces; 2012 Mar; 91():242-9. PubMed ID: 22137614 [TBL] [Abstract][Full Text] [Related]
27. A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles. Sekerdag E; Lüle S; Bozdağ Pehlivan S; Öztürk N; Kara A; Kaffashi A; Vural I; Işıkay I; Yavuz B; Oguz KK; Söylemezoğlu F; Gürsoy-Özdemir Y; Mut M J Control Release; 2017 Sep; 261():187-198. PubMed ID: 28684169 [TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study. Poy D; Akbarzadeh A; Ebrahimi Shahmabadi H; Ebrahimifar M; Farhangi A; Farahnak Zarabi M; Akbari A; Saffari Z; Siami F Chem Biol Drug Des; 2016 Oct; 88(4):568-73. PubMed ID: 27178305 [TBL] [Abstract][Full Text] [Related]
29. Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting. Chu L; Wang A; Ni L; Yan X; Song Y; Zhao M; Sun K; Mu H; Liu S; Wu Z; Zhang C Drug Deliv; 2018 Nov; 25(1):1634-1641. PubMed ID: 30176744 [TBL] [Abstract][Full Text] [Related]
30. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells. Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189 [TBL] [Abstract][Full Text] [Related]
31. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles. Zhang Y; Yu J; Zhang L; Cai J; Cai D; Lv C Tumour Biol; 2016 Feb; 37(2):2703-8. PubMed ID: 26404136 [TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery. Alex AT; Joseph A; Shavi G; Rao JV; Udupa N Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603 [TBL] [Abstract][Full Text] [Related]
33. Nanoparticles: Novel vehicles in treatment of Glioblastoma. Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272 [TBL] [Abstract][Full Text] [Related]
34. Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy. Guo S; Wang Y; Miao L; Xu Z; Lin CM; Zhang Y; Huang L ACS Nano; 2013 Nov; 7(11):9896-904. PubMed ID: 24083505 [TBL] [Abstract][Full Text] [Related]
35. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme. Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131 [TBL] [Abstract][Full Text] [Related]
36. An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma. Xu HL; Mao KL; Lu CT; Fan ZL; Yang JJ; Xu J; Chen PP; ZhuGe DL; Shen BX; Jin BH; Xiao J; Zhao YZ Biomaterials; 2016 Nov; 107():44-60. PubMed ID: 27614158 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion. Huang CY; Chen CM; Lee YD Int J Pharm; 2007 Jun; 338(1-2):267-75. PubMed ID: 17368981 [TBL] [Abstract][Full Text] [Related]
38. [Preparation and in vitro release characteristics of vincristine sulphate loaded poly (butylcyanoacrylate) nanoparticles]. Tan R; Liu Y; Feng N; Zhao J Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1431-5. PubMed ID: 22779171 [TBL] [Abstract][Full Text] [Related]
39. In vitro effect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562. Hasandoost L; Akbarzadeh A; Attar H; Heydarinasab A Artif Cells Nanomed Biotechnol; 2017 May; 45(3):665-669. PubMed ID: 27133178 [TBL] [Abstract][Full Text] [Related]
40. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma. Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]